Abstract-Neural tube defect (NTDs) is the most severe from of congenital malformation of central nervous system leading to infant mortality and morbidity. The most common form of NTDs is anencephaly (spina bifida) and myelomeningocele. The incidence in the population varies depending on racial/ethical variation including genetic and unknown environmental factors. The etiopathology of NTDs is still unknown between two different gene, hence present study has been designed with the aims to evaluate gene mutation between tumour suppressor gene and leukaemia inhibitory factor during organogenesis. We have collected the blood samples (n= 43) of clinically diagnosed NTDs with respective controls (n= 46) for PCR based DNA analysis to evaluate the frequency of p53 and LIF gene mutation using specific primers. Present findings reveals that highly significant differences (P<0.05) were observed in LIF gene using two different exons confirming p53 gene inactivation influences neural ectoderm proliferation result increased "risk factor" for the development of NTDs.
Introduction
Human development of neural tube defect is highly complex process. The central nervous system is initially derived from monolayer tube during the process of neurulation. Neurulation comprises two phases-primary and secondary, earlier is responsible to the folding of an induced neural plate that occurs on the dorsal side of the embryo and results in the formation of the brain and spinal cord [1] [2] [3] . Secondary neurulation is a sequential process of canalization, differentiation of neural cord and further development of spinal cord. Hence, several morphogenetic factors play an important role during embryogenesis [4] . Globally, NTDs are the most severe problem associated with congenital malformations of central nervous system (CNS) leads to causes infant morbidity and mortality. The incidence is highly variable 0.2-3.3 per 1000 births depending on racial, ethical and geographical regions. Their incidence may be reduced the risk up to 75% after preconception supplementation of folic acid [5] [6] . Since the prevalence rates of NTDs is based on several factors including nutritional problems. Incomplete developments of CNS are generating various forms of NTDs such as anencephaly or as spina bifida and myelomeningocele (MMC). These are accompanied by alterations of the axial skeleton, as well as the overlying meningovascular or dermal tissues (canalization) [7] [8] . However, over 90% of the NTDs cases still have an unknown etiopathology. During normal differentiation, cell develops the ability to maintain genomic integrity by providing regulatory mechanism based on cell-cycle kinetics. Tumor suppressor gene (p53) is also called the "guardian of genome", essential for preventing inappropriate cell proliferation by arresting cell-cycle, helps to remove damaged cells by apoptosis, maintaining genomic integrity and DNA repair during stress [9] [10] .The p53, a nuclear phosphoprotein is expressed in normal as well as malignant cells condition [11] , highly conserved during evolution and its mutations causes amino acid substitutions increased instability for the development of abnormal neural tube closure including exencephaly [12] [13] . Since p53 has becomes the molecule of central focus of intensive basic and clinical research and molecular mechanisms are still not well implicit but its activation increase risk factor either alone or associated with cytokines in cancer patients [14] . Leukaemia inhibitory factor (LIF) is a pleiotropic cytokine belong to IL-6 family acts as a paracrine or autocrine fashion to regulate metabolic homeostasis through binding to a heterodimeric specific glycoprotein (gp190 & gp130), shared by several receptors of cytokines related to IL6 to maintain totipotent embryonic stem cells [15] [16] [17] becomes necessary to understand the function of LIF during organogenesis in NTDs [18] . Hence, there is considerable curiosity has been developed with the aim to determined, whether p53 gene mutation act as LIF suppressor or inducer to neural ectoderm during folding of neural tube defects. Therefore, present study becomes imperative to explore the mechanism of NTDs to understand the action of causative factors including gene-gene interactions by helping non invasive technique such as prenatal diagnose to prevent incidence of NTDs in the society.
Materials and Methods
Blood samples of NTDs (n = 43) were collected from the Obstetrics & Gynaecology & Paediatric Surgery, I.M.S., B.H.U.,Varanasi with their respective controls (n = 46), after written consent of patients/ attendant The criteria for inclusion of an individual were based on clinically diagnosed NTDS. The study was approved by ethical committee of the Institute. Genomic DNA was isolated from the whole blood using Bioner Kit (Korea) and samples were kept at-20ºC till further analysis. In the present study specific primers for p53 and LIF were selected forward 5'-TGA AGT CTC ATG GAA GCC AGC. and reverse 5'-GCT CTT TTC ACC CAT CTACAG-3' while for LIF exon 3a and 3b, forwards 5'-ACA ATT CCA GAT GCT TAC AGG G-3' and reverse 5'-GCC AAG GTA CAC GAC TAT GC-3' and forwards 5'-CCC AAC AAC CTG GAC AAG CTA TG-3' and reverse 5'-CCG TAG GTC ACG TCC ACA TG-3' respectively. We have used two different PCR specific strategies for p53 and LIF exon 3a and 3b gene using specific forward and reverse primers in volume of 25 µl contain 50-100 ng of DNA, 20 pmole of each primer, 200µM of each dNTPs mix with Taq buffer (10mM Tris HCl pH 8.3, 50mM KCl), 3.0mM MgCl2 and 3 unit of Taq polymerase (New England Biolab).For p53, cycling conditions were 3 min at 94ºC for initial denaturation, 60ºC/30sec for annealing followed by 35 cycles and 72ºC/5min for final extension while LIF exon 3a & 3b having same cycling conditions were 1 min at 94ºC for initial denaturation, 56ºC/1min for annealing followed by 35 cycles and 72ºC/78min for final extension. The PCR product was separated on 1.5% agrose gel, stained with Et.Br and bands were visualized and characterize on Gel Doc system (SR Biosystem). Table-1 showing the details finding of the p53 and LIF gene activity using polymerase chain reaction (PCR) based DNA analysis with specific amplicons to characterize mutational spectra in NTDs cases and compare the same with controls. We are able to characterize the gene mutation in terms of either complete disappearance (null) or up regulation (over expression)/down regulation (regression). To confirm the above findings the study was repeated three times. The optimal condition for amplification of DNA coding region of exon having length of the primer 279bp for the exploration of the p53 gene. In present study, p53 gene shows highest frequency (30.00%) of upregulation with O.R. [20] . Hence, this unusual behaviour of p53 gene mutation during organogenesis increases "risk factor" for development of neural tube defects. Interestingly, our study of p53 gene mutation showing also significant (p<0.05) difference suggesting inactivation of p53 gene might have responsible for modulation of LIF activity in neural ectoderm during neuralation. Similarly, Hosako, et al, 2009 [20] also revealed that deletion of p53 in NTDs is associated with NTDs to maintain genomic integrity during neural tube closure. Cytokine biology plays an important role during organogenesis. To identify LIF unequivocally as factor responsible for the folding of neural ectoderm either through paracrine or autocrine regulation, with or without interaction of p53.We have observed the significant changes in the activity of LIF [ Table- 1], confirming by using two different sets of forward/reverse primers for such noble study that how p53 regulates LIF activity in NTDs. LIF belong to the family interleukin-6 and little is known about regulation in NTDs, although, our study also reveals highly significant (p<0.001) differences were observed in down regulation (suppress) suggesting p53 gene mutation act as suppressor during organogenesis. However, our findings confirm that p53 gene inactivation modulating LIF activity either as inducer or suppressor by up or down regulation with increase "risk factor" for the development in NTDs. The two different forms of LIF encoding signals identical in biological functions and exhibits a tissue specific distribution in such cases. The epidemiological criteria serve as useful guide lines for collecting evidence to support relationship between loss of neural function and inactivation of p53 between genetic and epigenetic pathway. Although, our findings shows a significant relationship between LIF regulatory mechanisms during neural tube closure. Such consistency and biological gradient relationship together with well recognised function of p53 makes our study more strengthen the association of LIF activity in etiopathology of NTDs during neuralation, hence we hypothesize that on the basis of our present findings that cytokines regulation during organogenesis play an essential role during cell differentiation and their transcription modulates by p53 gene inactivation increase "risk factor" for the development of NTDs.
Results
Tumour Suppressor Gene (p53) Modulates LIF Activity -A Causative Factor for the Development of Neural Tube Defects in
Conclusion
In human, the exact causes of neural tube defect are still unclear but believe to be multifactorial gene-gene interaction, therefore, we conclude from the present study to across the first time association between p53 gene and LIF gene in NTDs with four possible reasons associated with such disorders: 1. p53 gene inactivation increased "risk" as an independent factor for NTDs. 2. Severity of the disease such as anencephaly is equally important for developing complications during organogenesis due to p53 & LIF gene mutation. 3. LIF gene activity confirm their association either as an independent or association with p53 gene mutation. 4. Genetic heterogeneity in population varying age, sex and belongs to different ethnic groups modulate LIF activity either due to severity of the disease or tissue specific genetic susceptibility. Hence, plausibly hypothesize that significant association of two different genes are associated for the development of clinically diagnosed NTDs. Although, our study is small but promising to further evaluation to confirm gene-gene interaction to induce congenital malformations of central nervous system leading "Birth Defects".
